长风药业(02652.HK)：建议采纳H股奖励计划
CF PHARMTECHCF PHARMTECH(HK:02652) Ge Long Hui·2025-11-12 23:10

Core Viewpoint - Changfeng Pharmaceutical (02652.HK) has announced the adoption of the H-share incentive trust plan aimed at aligning the interests of employees, management, and shareholders, thereby attracting, retaining, and motivating key talents to drive the company's sustainable development and long-term success [1] Group 1 - The H-share incentive plan is set to be implemented on November 12, 2025 [1] - The primary goal of the plan is to ensure the alignment of interests among employees, management, and shareholders [1] - The initiative is designed to attract, retain, and motivate key talents while rewarding their contributions [1]